Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
EPYSQLI, a biosimilar referencing Soliris1 (eculizumab), is Samsung Bioepis' first biosimilar in hematology to be recommended for marketing authorization by the European Medicines Agency INCHEON, Korea
Samsung Bioepis Obtains Two ISO Certifications for Environmental Management System and Energy Management System | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.